NIH-supported study pinpoints origin of 2009 H1N1 influenza pandemic
Researchers have used genetic sequencing to show that the 2009 global H1N1 influenza pandemic began in central Mexico, originating in pigs and spreading to humans. Mexico is not typically considered a source of novel influenza strains. The new findings appear online in the journal eLIFE. They shed light on how the novel virus evolved and stress the need for improved influenza surveillance. The research was supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health,
The U.S. Centers for Disease Control and Prevention estimates that nearly 300,000 people died worldwide during the 2009-2010 flu season as the result of pandemic H1N1 infection. The pandemic H1N1 influenza virus that emerged that season was not previously known to infect people and is unrelated to the human seasonal H1N1 viruses that have circulated since 1977. Its global spread caused severe illness and death patterns not normally seen in seasonal influenza infections. The new study suggests that the first human outbreak of pandemic H1N1 occurred in Mexico in early 2009; no other related swine influenza viruses had been detected in Mexico or any part of the Americas.
The new research suggests the need to track the geographical distribution of influenza type A viruses, including H1N1, in global swine populations. Future influenza pandemic preparedness will require improved viral surveillance and an understanding of how economic forces and international trade policies affect changes in animal movements and production practices that contribute to viral outbreaks, the authors write.
I Mena, M Nelson, F Quezada-Monroy et al. Origins of the 2009 H1N1 influenza pandemic in swine in Mexico. eLIFE DOI: 10.7554/eLife.16777 (2016).
NIAID Director Anthony S. Fauci, M.D.; David Spiro, Ph.D., chief, Influenza, SARS, and Related Viral Respiratory Diseases Section, in NIAID's Division of Microbiology and Infectious Diseases; and Martha Nelson, Ph.D., research fellow, Fogarty International Center, are available for comment.
To schedule interviews, please contact Emily Mullin, (301) 402-1663, [email protected]
NIAID conducts and supports research — at NIH, throughout the United States, and worldwide–to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.
NIH…Turning Discovery Into Health®